CARB-X

CARB-X is a US-based global nonprofit partnership that provides non-dilutive funding and support to early-stage antibacterial companies developing products to combat antibiotic-resistant bacteria. The organization supports pre-seed and seed stage companies working on innovative antibiotics, vaccines, rapid diagnostics, and other therapeutics addressing the threat of drug-resistant infections. CARB-X accelerates the development of promising biotech solutions through funding, strategic guidance, and connections to global networks.

CARB-X